Sen. Cory Booker calls for more transparency in Medicaid drug decisions

Sen. Cory Booker, D-N.J., says he will introduce federal legislation this week that would require more transparency surrounding states' Medicaid drug decisions. The bill comes in response to a recent investigation by the Center for Public Integrity and NPR. The measure, known as the "Medicaid Drug Decisions Transparency Act," would require pharmaceutical companies to disclose their payments to pharmacists and others who serve on state Medicaid drug boards.